Guidant Cites Ethics In Countering Drug-Eluting Stent Data Enjoinment
This article was originally published in The Gray Sheet
Executive Summary
Guidant is relying on two ethical arguments to persuade a federal judge not to block access to clinical drug-eluting stent data collected in collaboration with Cook, Inc
You may also be interested in...
Guidant’s $3 Bil. Cook Purchase Hinges On Ownership Of Subsidiary, Data
Guidant's $3 bil. purchase of Cook Group does not represent a "change of ownership" under the terms of a 1997 licensing agreement between subsidiary Cook, Inc., Angiotech Pharmaceuticals and Boston Scientific, Guidant asserts
Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
Hair Supplement Linked To Cases Of Severe Hepatitis In France
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: